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A B S T R A C T
Introduction: Moxibustion is an ancient method of traditional medicine (along with acupuncture) using
moxa, or processed mugwort leaves. Both the smoke and heat generated by burning moxa are considered
to have therapeutic effects. However, recently there have been reports of harmful substances released in
smoke from everyday objects such as scented candles or incense. Therefore it appeared to be important to
evaluate the safety of products resulting from the combustion of moxa.
Methods: We used three types of commonly used moxa. Experiments were conducted by lighting moxa
which had been classiﬁed according to their level of reﬁnement. Gases released were collected after
igniting moxa. A gas chromatograph mass spectrometer (GC/MS) was used for both qualitative and
quantitative analysis. Standard conditions for Japanese therapeutic environments were employed.
Results: 1,3-butadiene was present from the smoke at the highest level of concentrations of substances
governed by assorted indoor air quality and environmental standards (1,3-butadiene, benzene, toluene,
ethylbenzene, and xylene) and fell below maximum values. Also, simulation in an indoor environment
with 1,3-butadiene was safely within indoor environmental standards.
Conclusion: Our simulation results have shown that quantities of harmful substances released upon
combustion of moxa during normal clinical therapy of Japan are below maximum levels. Hence are safe
for both patient and practitioner. However we detected few amounts of harmful substances released
from moxa. These harmful substances are invariably generated upon combustion, although varieties and
quantities vary according to substance. So measures to maintain an appropriately safe work environment
must be practiced, even though safety was conﬁrmed.
ã 2016 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Traditional medicine’s acupuncture and moxibustion began in
ancient times in China, and were transmitted largely within East
Asia, where throughout the ages techniques were passed down in a
closely-knit relationship with local traditions and customs.
Moxibustion originally was considered to be performed with
materials other than moxa or methods to expose affected parts of
the body to smoke [1,2], but mugwort leaves came to be the ﬁnal
source of heat. Not only is mugwort a common plant and thus
easily procured, but dried leaves of the plant burn in a steady and
pleasing manner. Smoke released upon burning of the leaves also* Corresponding author at: Chiba University Hospital, 1-8-1 Inohana, Chuo-ku,
Chiba-shi, Chiba Prefecture 260-8677, Japan.
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4.0/).has a pleasant fragrance, which has been reported to have a variety
of effects [3]. This smoke is believed to have a sterilization effect [4]
in China, and basic research of its effect has been published [5].
Many combustion products are released in smoke when moxa
burns, although the same can be said of any substance. Such
combustion products may include substances both innocuous and
harmful to humans, although even harmful substances may be
handled in such a way as to render them innocuous. National
standards governing such substances can vary according to
country, but there exist environmental and safety standards
requiring that any products exported must comply with. Examples
are formaldehyde and 1,3-butadiene, well-known carcinogenic
combustion products released upon burning of a multitude of
everyday goods. Marco et al. [6] have studied the toxicity of candles
containing chemical substances such as fragrances.
In recent years there have been efforts to standardize
moxibustion implements and techniques throughout the world,le under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
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modern scientiﬁc analysis to bear on the treatments. There have
already been studies of the constituent ingredients of the base
ingredient mugwort and the processed substance moxa [7].
However, there has been no such analysis of the constituent
products of smoke released upon burning moxa [8,9]. In particular,
there have been no reports on the safety of smoke from moxa
produced in Japan.
Therefore, in this study we analyzed the substances contained
in smoke released from moxa upon combustion, compared these
with relevant standards, and performed a simulation on practi-
tioner exposure.
2. Materials and methods
2.1. Materials
We used three types of moxa, each reﬁned to a different degree:
Tenkyu, Kyutoshin, and Onkyu. In Japanese moxibustion practice,
these three types of moxa are used with different techniques
according to therapeutic goals [10,11]. Type of moxa used primarily
depends upon degree of reﬁnement (Fig. 1). Differing degrees of
reﬁnement generate different quantities of heat, and different
treatments require different temperatures. A lower degree of
reﬁnement moxa means a higher level of foreign substances in the
leaves, causing higher temperatures upon combustion.
High-reﬁned moxa is used with Tenkyu treatment methods,
which are practiced primarily in Japan. In this treatment, a moxa
cone (twisted moxa for combustion), with about half- to full-size of
a rice grain, is placed directly on the skin and gives small burn with
an incense stick. High-reﬁned moxa is manufactured by ﬁrst
grinding the leaves in a stone mill, then bamboo implements
known as Nagatoshi and grain fans combined with sieves to
produce the ﬁnal product. This type of moxa requires a trained and
experienced craftsman to produce, and is golden in color. About
100 kg of dried mugwort leaves yields about 3 kg of Tenkyu moxa.
Medium-reﬁned moxa is used in Kyutoshin and Chinetsu-kyu
therapy methods. In Kyutoshin, moxa is afﬁxed to the handle of the
needle inserted into the patient, then burned to heat the skin
through radiant heat. Chinetsu-kyu therapy may use either a moxa
tube or a cardboard base to provide an indirect thermal stimulus to
the skin. About 100 kg of dried mugwort leaves yields about 15 kg
of the medium-reﬁned moxa.
Finally, low-reﬁned moxa is used in Onkyu therapy, a method to
warm the affected part with radiant heat using larger moxa cones
than those for Tenkyu or moxa sticks, or indirect heat with medicalFig. 1. Moxa sizes in Japan depending on treatment methods. Different levels of purity a
types of moxa.herbs placed between a moxa cone and the skin. Therefore,
relatively un-reﬁned moxa is used as it provides a higher
temperature upon combustion. About 100 kg of dried mugwort
leaves yields about 30 kg of this type of moxa.
In this study we used three types of moxa of different grades
produced by a major Japanese producer of moxa for clinical use.
Sample 1 (S1) was high-reﬁned moxa (Tenkyu), sample 2 (S2) was
medium-reﬁned moxa (Kyutoshin), and sample 3 (S3) was low-
reﬁned moxa (Onkyu).
Study measurements were performed by the Chemicals
Evaluation and Research Institute, Japan.
3. Methods
We collected smoke for qualitative analysis of the materials
released from the smoke. Only substances governed by the
environmental standards were subjected to the quantitative
analysis and measurement of the density. In addition, we
measured the density of carbon monoxide (CO) and carbon
dioxide (CO2) by gas-detecting tube test. These results were
subsequently used to perform a simulation of exposure to the
substances.
3.1. Test method
3.1.1. Qualitative analysis
S1, S2 and S3 were ignited, placed in a glass combustion
chamber, then subjected to a high-purity air stream produced by a
mass ﬂow controller (75 mL/min for S1 and 500 mL/min for S2 and
S3). Gasses released from the combustion chamber were captured
in a Tedlar bag. Gas collected in this manner was then aliquoted
with a gas-tight syringe (1 mL, or 5 mL for low-concentration
samples) and transferred to a gas chromatograph mass spectrom-
eter (GC/MS) with a liquid argon cold trap at the column entrance.
After concentration, the liquid argon container was removed from
the thermostatic bath and heated rapidly to perform qualitative
analysis.
3.1.2. Quantitative analysis
Next, quantitative analysis was performed on substances
identiﬁed from the qualitative analysis which are particularly
harmful and regulated according to standards or guidelines
concerning indoor air quality or environmental pollution
(1,3-butadiene, benzene, toluene, ethylbenzene, xylene, CO, and
CO2). Quantities of these substances were evaluated according to
the following standards: Japan’s Law for Maintenance of Sanitationnd sizes are used in Japan depending on treatment method. This ﬁgure shows three
Fig. 2. Schematic of combustion testing apparatus. This schematic shows the process from moxa combustion to gas collection.
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Ministry of the Environment’s (MOE) environmental regulations
[14], and the Japanese Ministry of Health, Labor, and Welfare’s
(MHLW) indoor concentration guideline values [15]. The Japanese
indoor concentration values for chemical substances are “Chemical
substance concentrations below which even a lifetime of exposure
should result in no harmful effects, as based on currently available
scientiﬁc evidence.”
3.1.3. Detector tube test
 Gas sampling pump: GV-100SFig. 3. Sample 1 moxa shaped into two 1-mg cones each placed side by side CO rapid detector tube No. 1L (Gastec)
 CO2 rapid detector tube: No. 2L (Gastec)
3.2. Reagents and equipment
 Air: Puriﬁed Air G-3(Japan Fine Products)
 Tedlar bag: 3 L type A (Omi Odor-Air Service)
 Mass ﬂow controller: SEC-40 (Horiba Stech). This ﬁgure shows 1-mg samples on the combustion chamber platform.
Fig. 4. Samples 2 and 3 shaped into 40-mg cones. This ﬁgure shows 40-mg samples on the combustion chamber platform.
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3.3.1. Combustion device
A schematic of the combustion device used is shown in Fig. 2.
A preliminary cleaning of the combustion chamber was
performed with water and methanol, then it was further cleaned
with a heat gun while passing through 1 L/min air for approxi-
mately 20 min.
3.4. Samples
Experiments used moxa samples of the same size and shape
generally used in clinical situations in Japan in order to best reﬂect
actual use [10,11].Fig. 5. Combustion methods for moxa cones using the combustion chamber. TTowards this end, for S1 (high-reﬁned moxa for Tenkyu) two
cones of about 1 mg each were placed side-by-side (Fig. 3), while
for S2 (medium-reﬁned moxa for Kyutoshin) and S3 (low-reﬁned
moxa for Onkyu) 40 mg cones were used (Fig. 4).
3.4.1. Sample 1
One mg of sample was precisely measured out and shaped into
a cone; two of these were placed on a stand and ignited with an
electrical ﬁlament before being placed in the combustion
chamber. A mass ﬂow controller was used to blow high-purity
air adjusted to 50% RH over the samples for exactly 1 min at a ﬂow
rate of 75 mL/min. This operation was repeated ﬁve times, and the
gas released trapped in gas collection bags to be used as samples
for measurement. This entire process was performed two times
for a total of ten data calculations.his ﬁgure shows details of the process used in the combustion chamber.
Fig. 7. Algorithm for average air concentration of exposure duration. This is the formula for calculating average air concentration of exposure duration in therapy room
simulation.
Fig. 8. Algorithm for concentration during use. This is the formula for calculating concentration during use in therapy room simulation.
Fig. 9. Algorithm for calculating average air concentration during post-use stay. This is the formula for calculating average air concentration during post-use stay in therapy
room simulation.
Fig. 6. 1,3-Transition of butadiene concentration by moxibustion in the therapy room. This ﬁgure shows simulated substance levels in therapy rooms.
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igniting the samples as a control. Fig. 5 shows the moxa
combustion methods.
3.4.2. Sample 2 and sample 3
Forty mg of the sample was precisely measured out, shaped into
a cone, then placed on a stand before being ignited with an
electrical ﬁlament and placed in the combustion chamber. A mass
ﬂow controller was used to blow high-purity air over the samples
for exactly 3 min at a ﬂow rate of 500 mL/min. Gas released was
trapped in Tedlar bags to be used as samples for measurement.
Before measuring these samples, the same process was used on
S2 without igniting the moxa to obtain control samples. Fig. 5
shows the moxa combustion methods.
3.5. Measurement conditions
3.5.1. Gas chromatography/gas chromatograph mass spectrometer
(GC/MS) measurement conditions
 Device: 5973MSD (Agilent Technologies)
 Column: Equity-1 (SUPELCO), diameter 0.32 mm, length 60 m,
membrane thickness 5.0 mm
 Column temperature: 40 C for 7.0 min (5 C/min.), then 20 C
(20 C/min.), then 250 C (for 2.5 min) Sample insertion point: 250 C
 Sample injection volume: 1.0 mL
 Sample insertion method: Splitless injection with cold trap at
temperature of liquid argon. Analysis initiated 2 min after
column head pressure returned to room temperature value
(120 kPA) (about 5 min).
 Carrier gas: Helium (1.2 mL constant ﬂow mode)
3.5.2. Gas chromatography/ﬂame ionization detector (GC/FID)
measurement conditions
 Device: 6890 N (Agilent Technologies),
 Column: Equity-1 (SUPELCO) diameter 0.32 mm, length 60 m,
membrane thickness 5.0 mm
 Column temperature: 40 C for 7.0 min (5 C/min.), then 20 C
(20 C/min.), then 250 C (for 2.5 min)
 Sample insertion point: 250 C
 Sample injection volume: 5 mL
 Sample insertion method: Splitless injection with cold trap at
temperature of liquid argon. Analysis initiated 2 min after
column head pressure returned to room temperature value
(120 kPA) (about 5 min).
 Carrier gas: Helium (1.2 mL constant ﬂow mode)
Table 1
Sample 3 qualitative results (102 compounds). This Table lists all compounds detected in sample 3, which exhibited the largest number of combustion products in the
experiment.
Peak
No
Name of
compound (libraly
serch results)
retention
time
(min)
Peak
No
Name of
compound (libraly
serch results)
retention
time
(min)
Peak
No
Name of compound
(libraly serch results)
retention
time
(min)
Peak
No
Name of compound
(libraly serch results)
retention
time(min)
#1 Carbon dioxide 2.692 #27 Cyclopentylethyne 10.93 #53 2-Propyn-1-ol 19.555 #79 Styrene 26.795
#2 Ethane 2.824 #28 Propanal, 2-
methyl-
11.154 #54 Furan, 2,5-dimethyl- 19.734 #80 o-Xylene 26.921
#3 1-Propene 3.346 #29 Propanenitrile 11.289 #55 Heptane 19.903 #81 2-Cyclopenten-1-
one, 3-methyl-
27.863
#4 Propane 3.402 #30 2-Butenal 11.741 #56 2-Cyclopenten-1-
one, 3-methyl-
20.102 #82 Phenol 27.986
#5 Water 3.746 #31 Cyclopentene 11.889 #57 Pyrimidine 20.405 #83 Corylone 28.883
#6 Methane, chloro- 3.948 #32 2-Butanone, 3-
methyl-
12.503 #58 Phenol 20.564 #84 Benzene, 1-methyl-4-
(1-methylethyl)-
29.144
#7 Acetaldehyde 4.262 #33 Acetic acid 13.095 #59 Furan, 2,3-dihydro-3-
methyl-
20.671 #85 2-Methylphenol 29.2
#8 1-Propene, 2-
methyl-
4.762 #34 1-Hexene 13.841 #60 Acetamide 20.887 #86 Limonene 29.318
#9 1,3-Butadiene 4.877 #35 Furan, 2-methyl- 14.127 #61 1H-Pyrrole, 1-
methyl-
20.959 #87 Phenol, 4-methyl- 29.419
#10 Butane 5.028 #36 Hexane 14.48 #62 Pyridine 21.263 #88 3-Pyridinol 29.483
#11 1-Butene 5.289 #37 Furan, 2-methyl- 14.713 #63 Pyrrole 21.389 #89 N-Methyl-2-
benzyloxyethylamine
29.64
#12 Methane, bromo- 5.583 #38 Pentane, 3-
methylene-
14.836 #64 Disulﬁde, dimethyl 21.549 #90 Pentanamide, 4-
methyl-
29.752
#13 1-Butene 5.704 #39 Cyclopentene, 1-
methyl-
15.133 #65 3-Butene-1,2-diol 21.725 #91 Phenol, 2-methoxy- 29.823
#14 1-Propanamine 6.186 #40 2,4-Hexadiene 15.615 #66 Propanoic acid, 2-
oxo-, methyl ester
22.028 #92 Benzoic acid 30.425
#15 Acetonitrile 6.778 #41 2-Butenal 15.876 #67 Toluene 22.933 #93 Phenol, 2-ethyl- 30.624
#16 Acrolein 7.184 #42 2-Propanone, 1-
hydroxy-
16.26 #68 1,4-Cyclohexadiene,
1-methyl-
23.124 #94 1,2-Benzenediol 30.851
#17 Acetone 7.537 #43 1,3,5-Hexatriene 16.507 #69 Hexanal Aldehyde 23.713 #95 Benzofuran, 2,3-
dihydro-
31.152
#18 1-Pentene 8.348 #44 Butanal, 2-methyl- 17.084 #70 3-Furaldehyde 23.833 #96 1,2-Benzenediol,
diacetate
31.471
#19 Furan 8.449 #45 Cyclopentene, 3-
methyl-
17.334 #71 1-Octene 24.083 #97 1,3-Benzenediol 31.611
#20 2-Propenenitrile 8.679 #46 Benzene 17.519 #72 Pyridine, 2-methyl- 24.512 #98 CinnamicAldehyde 31.676
#21 Pentane 8.928 #47 Propanoic acid 18.027 #73 2-
Furancarboxaldehyde
24.652 #99 Indole 32.534
#22 1,3-Butadiene, 2-
methyl-
9.186 #48 1,3-
Cyclohexadiene
18.15 #74 2-Propanone, 1-
(acetyloxy)-
25.238 #100 3-methoxy
acetophenone
32.78
#23 2-Butene, 2-
methyl-
9.657 #49 2,3-Pentanedione 18.355 #75 2-Furanmethanol 25.339 #101 Phenol, 2-(1-
methylethoxy)-,
methylcarbamate
33.081
#24 2-Butene, 2-
methyl-
9.946 #50 Cyclopentanol 18.708 #76 Ethylbenzene 26.155 #102 1,3-Benzenediol, 4-
ethyl-
33.423
#25 1,3-Pentadiene, 10.092 #51 Cyclohexene 18.882 #77 p-Xylene 26.352
#26 1,3-
Cyclopentadiene
10.767 #52 1-Heptene 19.314 #78 Quinone 26.657
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Based upon the results obtained above, simulations of indoor
air concentration during moxibustion therapy were performed for
1,3-butadiene, which was the highest-concentration substance
detected (among 1,3-butadiene, benzene, toluene, ethylbenzene,
and xylene). Exposure levels were calculated according to
measurements obtained from S2, as this sample resulted in the
highest levels.
3.6.1. Exposure scenario
The scenario assumes moxibustion therapy in a room with a
volume of 20 m3, with no transdermal exposure, only inhalation of
smoke and its constituent combustion products. If moxa less than
medium-reﬁned is burned directly on the skin, complete
combustion can cause scarring because about 40 mg of moxa is
used. Therefore, recently in Japan the moxa is removed from theskin and extinguished as soon as it reaches therapeutic temper-
atures.
Therefore, we assumed a combustion ratio of 63% for each piece
of moxa in our simulation of the combustion product 1,3-
butadiene. Eighteen pieces of 40-mg moxa were used in one
treatment. Each piece burns for 30 s, so the entire combustion time
is 9 min. We assume that therapy rooms will either have a
ventilation system or windows, resulting in 0.5 air changes per
hour in the simulated therapy room with volume of 20 m3.
3.6.2. Algorithm
Fig. 6 shows concentration of 1,3-butadiene in indoor air during
a therapy session: repeated combustion causes elevated concen-
trations which taper off as the treatment ends, followed by a
decrease due to ventilation. The formula for calculating Cati
(average air concentration of exposure duration) is shown in Fig. 7.
Concentration during use, Cai must incorporate factors such as
elevation of concentration during combustion and decrease due to
ventilation, which is shown as an algorithm in Fig. 8. Finally, Fig. 9
Table 2
Results of detector tubes measurement CO and CO2 were detected in the qualitative
analysis. These are regulated substances, so they were measured quantitatively as
well.
Name of samples Number of tests Converted score of indoor area
of 20m3
Non-ventilated
CO2 CO
ppm ppm
Sample1 First time 0.45 0.08
Second time 0.38 0.09
Average 0.42 0.09
Sample2 First time 0.56 0.11
Second time 0.56 0.11
Average 0.56 0.11
Sample3 First time 0.75 0.11
Second time 0.75 0.10
Average 0.75 0.11
Notes: CO2: Management standards of Japan's Law for Maintenance of Sanitation of
Building are less than 1000 ppm.
CO: Management standards of Japan’s Law for Maintenance of Sanitation of Building
are less than 10 ppm.
420 T. Matsumoto et al. / European Journal of Integrative Medicine 8 (2016) 414–422shows the algorithm Catii (average air concentration during post-
use stay).
4. Results
4.1. Qualitative results
Qualitative analysis of volatile organic compounds present in
moxa combustion smoke after burning 40 mg of each sample
showed 66 compounds in S1, 99 in S2, and 102 in S3. Table 1 shows
a list of compounds detected in S3.
5. Quantitative results
1) Results of detector tubes measurement
Table 2 shows detector tube measurements for CO2 and CO.
These levels assume a 20 m3 therapy room volume with no
ventilation. S1 values were converted to those representing about
40 mg in order to enable comparison with S2 and S3.Table 3
Results of volatile organic compounds analysis this table shows concentrations of regulate
estimated concentrations in an unventilated 20 m3 room.
Name of substances
1,3-butadiene Benzene 
Sample1 First time 0.22 0.12 
Second
time
0.30 0.14 
Average 0.26 0.13 
Sample2 First time 0.35 0.27 
Second
time
0.33 0.26 
Average 0.34 0.27 
Sample3 First time 0.13 0.12 
Second
time
0.16 0.17 
Average 0.15 0.15 
Standards and
policies
1 ppb
(UK’s air quality
standards)
0.94 ppb
(MOE environmental
regulations)
ppb: Converted concentrations of non-ventilated indoor area of 20m3.Figures for S2 and S3 in Table 1 were measured twice each.
These concentrations were evaluated according to Japan’s Law for
Maintenance of Sanitation in Buildings, the statutes which govern
these substances. The law stipulates 1000 ppm or below for CO2
and 10 ppm or below for CO. As Table 2 shows, S1, S2, and
S3 yielded concentrations below the regulated maximum (average
of two measurements).
2) Results of volatile organic compounds analysis
Table 3 shows concentrations of substances regulated by
various standards and policies governing indoor air and environ-
mental pollution (1,3-butadiene, benzene, toluene, ethylbenzene,
and xylene), as well as converted concentrations of these assuming
a non-ventilated treatment area of 20 m3. S1 values were
converted to those representing about 40 mg in order to enable
comparison with S2 and S3 (average of two measurements used).
Table 2 shows substance concentrations according to various
standards, which differ according to entity. As shown in Table 3, all
samples resulted in concentrations within standard limits (average
of two measurements).
6. Results of simulation of indoor air concentration during
therapy
The formulae described above were used to calculate concen-
trations over time.
Cati = 6.76 mg/m3 (average air concentration of exposure duration)
Cai = 13.3 mg/m3 (concentration at time of use)
Catii = 9.89 mg/m3 (average air concentration during post-use stay)
The ﬁnal formula used for calculating average air concen-
trations over time from beginning to end of therapy is as follows:
(Cai  ti+ Catii  tii)/(ti + tii)=0.0103 mg/m3 (10.3 mg/m3)
The threshold limit value—time-weighted average (TLV-TWA)
for 1,3-butadiene according to the American Conference of
Governmental Industrial Hygienists is 4.4 mg/m3 (2 ppm). There-
fore, levels detected in our study are not considered problematic.d substances (1,3-butadiene, benzene, toluene, ethylbenzene, and xylene) as well as
Toluene Ethylbenzene Xylene
0.05 0.01 0.01
0.06 0.01 0.02
0.06 0.01 0.02
0.24 0.05 0.19
0.25 0.04 0.17
0.25 0.05 0.18
0.22 0.04 0.10
0.28 0.06 0.15
0.25 0.05 0.13
70 ppb
(MHLW guideline
values)
880ppb
(MHLW guideline
values)
200ppb
(MHLW guideline
values)
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This study evaluated the composition of smoke produced by
three grades of Japanese moxa with difference in reﬁnement
degree and used in regular clinical moxibustion in Japan. We
examined the ingredient of the smoke at the time of the
combustion.
In order to enable comparisons, we performed the examination
under the worst environment, with no ventilation in calculating
simple estimates of harmful combustion products in each sample.
However, to develop the exposure scenario for simulation, we
assumed and calculated under the actual clinical environment
which could ventilate by a ventilation fan or windows. That
complies with the structure and facility standards [16] regulating
acupuncture and moxibustion therapy rooms which dictate that
“at least one-seventh of the therapy room’s area be open to outside
air, or use an equivalent ventilation system.”
Our experiments used 1 mg of S1 and 40 mg each of S2 and S3,
reﬂecting actual clinical quantities. In preliminary experiments we
used 40 mg of S1 as well, resulting in higher concentrations of
1,3-butadiene and benzene released than either S2 or S3, although
still below the maximum standards assuming an unventilated
20 m3 therapy room. These values were higher for S1 because its
higher level of puriﬁcation resulted in ﬁner, denser plant ﬁbers.
Therefore, it may be assumed that when a 40 mg cone of moxa is
burned in the same manner as our preliminary experiments, air
does not reach the core of the cone, causing incomplete
combustion. Therefore, S1 was prepared to have 1/20 of quantity
and an increased ratio of surface area by dividing in half. This
quantity of 1 mg for S1 conforms to that used in medical practice. In
addition, we changed ﬂow volume and the ventilation time with
S2 and S3 at the time of the examination. Nevertheless, the
ventilation volume per 1 mg of sample was maintained at 37.5 mL/
g under the same condition.
Levels of CO2 and CO released upon moxa combustion were
below Japanese environmental standards, and were not problem-
atic. Meanwhile, volatile organic compounds were evaluated
according to UK environmental standards, as Japan lacks such
standards for 1,3-butadiene. Measurement results showed accept-
able levels of 1,3-butadiene, benzene, toluene, ethylbenzene, and
xylene. The aldehydes formaldehyde, acetaldehyde, and acrolein
were detected, but quantitative analysis of all three samples
demonstrated that levels generated fell below WHO guidelines
[17] as well as MHLW’s indoor concentration guideline values [15].
Harmful substances may be released upon either complete or
incomplete combustion. Recent years have seen increasing study
of indoor air pollution arising from a multitude of familiar,
everyday sources, from wood stoves [18,19] to incense [20,21] and
candles [6,22]. Even wood untreated with any chemical additives
generates harmful substances when burned, and the same is true
for moxa produced from natural mugwort leaves alone. In this
study we detected harmful substances released, albeit in very
small amounts, from moxa used clinically in Japan. These harmful
substances are invariably generated upon combustion, although
varieties and quantities vary according to substance. This becomes
problematic when such quantities exceed standards. According to
Mo et al. [8]. combustion of Chinese moxa sticks releases “toluene,
xylene, formaldehyde, and benzene.” Simulations assuming
Chinese clinical use resulted in high concentrations for some
substances.
For this reason, we determined it necessary to study the
question of exposure in Japanese clinical practitioners of moxi-
bustion exposed to the smoke for long periods of time. In
particular, our analysis focused on 1,3-butadiene, the substance
released in greatest quantities, in usage simulations modeled on
the size of Japanese therapy rooms as well as moxa size, shape, andquantity. Our calculation assumed a moxa combustion rate of 63%,
as recently in Japan 40-mg moxa cones are often removed from the
skin once the patient feels heat in order to avoid scarring. The 63%
ﬁgure was obtained by precisely measuring out about 40 mg of
S2 moxa, igniting it on the back of the hand, then extinguishing it
with nitrogen gas just prior to the heat becoming painful. The
combusted portion was then removed, the non-combusted portion
weighed, and the two weights used to calculate the percentage of
moxa burned. This process was repeated three times to obtain the
63% combustion rate for S2 moxa.
Our measurement and simulation results have shown that
quantities of harmful substances released upon combustion of
moxa during normal clinical therapy of Japan are below maximum
levels, and hence are safe for both patient and practitioner.
However, benzene and other harmful substances are present in
moxa smoke, so measures to maintain an appropriately safe work
environment must be practiced. Such measures may include
installing ventilation equipment or manually ventilating the room
sufﬁciently after each therapy session to reduce indoor air
concentrations present at the beginning of each session.
In Chinese practice [9], extremely large quantities of medium-
reﬁned moxa sticks are regularly used for therapy, resulting in
different levels of harmful combustion products compared to
Japan. A report cites ﬁve doctors using 24,000 moxa sticks over the
course of a single year. Further, moxa sticks are wrapped in paper,
which also burns during therapy. Moxa sticks are also compressed,
leading to more incomplete combustion due to lack of available
oxygen inside the stick. These differences should be studied in
more detail going forward. In addition, since incense is used in
Japanese Tenkyu therapy to ignite the moxa, incense smoke should
be subjected to the same analysis as the moxa itself.
Finally, though the exposure evaluation was found feasible only
by simulation in this study, it would be necessary to examine the
density of harmful combustion products in the actual clinical
environment in the future.
8. Conclusions
We studied the safety of combustion products in smoke
produced by burning moxa used in Japanese moxibustion therapy
according to qualitative and quantitative analysis of three common
types of moxa, each with a differing level of reﬁnement. Harmful
substances were detected, although in extremely small quantities
that fell below national safety standards according to both detector
tube measurement and volatile organic compound analysis.
A simulation was performed on indoor air concentrations of
1,3-butadiene, and levels were found safely within applicable
indoor environment standards.
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